Registry for adults with nontuberculous lung infection
Part of Lungs & breathing clinical trials.
This is a research registry that collects information from adults diagnosed with nontuberculous mycobacterial (NTM) lung disease. It may help doctors better understand the disease and improve care over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 20 or older
- Have been diagnosed with nontuberculous mycobacterial (NTM) lung disease using the ATS diagnosis criteria
- Be able to meet the study’s basic registry enrollment steps (forms, information sharing, and follow-up if needed)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a program of exercise and airway clearance education helps people with nontuberculous mycobacterial (NTM) lung disease. It aims to improve breathing and quality of life.
This trial tests whether a structured exercise program can improve symptoms and quality of life in people with nontuberculous mycobacterial (NTM) lung disease. If you have a confirmed NTM lung infection and are having respiratory symptoms, this study may help you build strength and better manage your condition.
This study looks at how your diet (nutrition) and your immune system's T cells (a type of white blood cell) may affect the progression of a lung infection caused by nontuberculous mycobacteria (NTM). Researchers will use samples from a bronchoscopy to check your immune activity and nutrition, which may help understand the disease and guide better care.
This study is a registry that collects health information from adults who have bronchiectasis caused by non-tuberculosis mycobacteria (NTM). It helps researchers better understand this condition and improve future treatments.
This study will build a Canadian registry for people with bronchiectasis (not from cystic fibrosis) and NTM infections. The goal is to track health outcomes over time to improve care.
This study creates a registry of patients in Austria who have a lung infection caused by tuberculosis or similar bacteria. By joining, you help researchers learn more about these infections and how to better treat them.
Hear when a new Nontuberculous Mycobacterial Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.